Milk-alkali syndrome classification

Revision as of 16:51, 21 April 2019 by Nabeel ahmed (talk | contribs)
Jump to navigation Jump to search

Classification

Milk- alkali syndrome may be classified as

Acute or toxemic form

  • The acute or toxemic form occurred after approximately one week of treatment
  • The symptoms are acute hypercalcemia
  • Nausea and vomiting
  • weakness
  • Mental changes with psychosis
  • Depressed sensorium
  • Severe metabolic alkalosis
  • Normal to elevated plasma phosphate concentration
  • Acute renal insufficiency
  • Withdrawal of milk and alkali led to rapid relief of symptoms and the return of normal renal function.
Subacute or Cope's syndrome
  • Patients were usually seen during therapy with milk and alkali that had been taken intermittently for years.
  • Affected patients had symptoms of both acute and chronic hypercalcemia and responded to medication withdrawal with gradual improvement. Renal function remained mildly impaired in some cases.
Chronic or Burnett's syndrome
  • Long history of high milk-alkali intake with symptoms of chronic hypercalcemia such as
  • Polyuria
  • polydipsia
  • Muscle aches, and pruritus
  • Evidence of metastatic calcifications, including band keratopathy and nephrocalcinosis
  • Laboratory abnormalities were similar to those in the acute syndrome, but the response to withdrawal of milk and alkali was quite different
  • The muscle aches and pruritus improved slowly as the plasma calcium concentration slowly normalized
  • There is usually minimal or no improvement in renal function, as many patients continued to have chronic renal failure.[1][2]

==References==

  1. BURNETT CH, COMMONS RR (May 1949). "Hypercalcemia without hypercalcuria or hypophosphatemia, calcinosis and renal insufficiency; a syndrome following prolonged intake of milk and alkali". N. Engl. J. Med. 240 (20): 787–94. doi:10.1056/NEJM194905192402001. PMID 18126919.
  2. Picolos MK, Lavis VR, Orlander PR (November 2005). "Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients". Clin. Endocrinol. (Oxf). 63 (5): 566–76. doi:10.1111/j.1365-2265.2005.02383.x. PMID 16268810.

Template:WH Template:WS